**Celosome IMPLANT**, developed by **NOVU Science** (South Korea), represents a distinct category within aesthetic augmentation: a **solid-state, biodegradable scaffold** designed for precise, long-lasting structural enhancement. Unlike traditional injectable fillers (HA, CaHA, PLLA), Celosome IMPLANT consists of pre-formed cylindrical rods composed of **Polycaprolactone (PCL)**. PCL is a biocompatible, synthetic polymer widely used in long-term medical implants (e.g., sutures, drug delivery devices, tissue engineering) known for its slow, predictable biodegradation profile (approximately 2-3 years).https://skin-reboot.com/

**Core Mechanism & Purpose:**
Celosome IMPLANT functions as a **3D volumetric scaffold**. Once inserted into the target tissue plane (typically supraperiosteal or deep subcutaneous), the solid PCL rods provide **immediate, stable structural support and projection**. The unique micro-architecture of the implant, featuring interconnected pores, allows for rapid host tissue integration. Fibroblasts and collagen-producing cells infiltrate the scaffold, leading to **neocollagenesis and neovascularization** within weeks. Over time, as the PCL slowly hydrolyzes, the newly formed autologous collagen network gradually replaces the implant material, maintaining volume and contour long after the polymer has fully degraded.

**Key Features & Benefits:**
* **Immediate Structural Lift & Projection:** Delivers significant volume augmentation instantly upon placement.
* **Long-Lasting Results:** Provides stable support for **24+ months**, leveraging both the scaffold’s persistence and subsequent collagen replacement.
* **Biocompatible & Predictable Degradation:** PCL is well-tolerated, breaking down into harmless byproducts eliminated via natural pathways.
* **Tissue Integration & Biostimulation:** Promotes natural tissue ingrowth and collagen production for sustained volumization.
* **Precise Placement & Shape Retention:** Solid form allows for accurate positioning and minimizes risk of migration compared to some injectables; maintains defined shape.
* **Minimal Swelling Post-Procedure:** Often associated with less immediate edema than large-volume liquid fillers.

**Primary Indications:**
* **Midface/Cheek Augmentation:** Restoring significant volume loss and providing structural lift.
* **Chin Augmentation:** Enhancing chin projection and contour.
* **Jawline Definition:** Strengthening and defining the mandibular angle and ramus.
* **Temple Volume Restoration:** Addressing significant temporal hollowing.

**Administration & Critical Considerations:**
* **Surgical Procedure:** Requires a **minor surgical intervention** under local anesthesia. A small incision (2-3mm) is made, and a **specialized trocar/cannula** is used to create a precise pocket at the target plane before inserting the pre-loaded implant rod.
* **Expertise Mandatory:** **Must be performed exclusively by surgeons or physicians** with specialized training in facial anatomy, surgical augmentation techniques, and the specific Celosome insertion protocol. Precision in pocket creation and implant positioning is critical.
* **Sterility & Asepsis:** Strict adherence to sterile technique is paramount to prevent infection.
* **Post-Operative Care:** Includes incision care, possible compression, and activity restrictions. Mild pain, bruising, and swelling are expected initially.
* **Potential Adverse Events:** Includes infection, hematoma, seroma, implant malposition, migration, asymmetry, palpability, visible edges, delayed inflammatory reactions (rare with PCL), nerve injury, or vascular compromise. Careful patient selection and meticulous technique are essential.
* **Regulatory Status:** Approved in various markets including South Korea (KFDA) and Japan (PMDA). Verify local approvals.

Celosome IMPLANT offers a unique solution for patients seeking significant, long-lasting structural augmentation with immediate results, leveraging the stability of a solid implant coupled with the regenerative potential of PCL-induced collagen synthesis. Its use demands significant procedural expertise.CONTACT US

The post Celosome IMPLANT first appeared on Svelte Path.